The judge in charge of Philadelphia’s Complex Litigation Center has written an opinion supporting his decision to toss 13 Risperdal cases that originated in Michigan.
Supervising Judge Arnold L. New issued an opinion earlier this month in response to an appeal to the Superior Court of 13 consolidated cases against drugmaker Janssen Pharmaceuticals explaining why he decided to apply Michigan law to the cases, all of which involve plaintiffs who were prescribed the antipsychotic Risperdal while living in Michigan. The plaintiffs have contended that the drug causes gynecomastia, a condition where men suffer from enlarged breasts.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
